|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000132561 |
Summary for MATN2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000132561 | Gene symbol | MATN2 |
| Gene name | matrilin 2 | |
| HGNC | 6908 | |
| Entrez ID | 4147 | |
| Gene type | protein_coding | |
| Synonyms | MATN2| | |
| UniProtAcc | O00339 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for MATN2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| MATN2 | 2.02e+03 | -1.71e+00 | 4.25e-01 | -4.03e+00 | 5.54e-05 | 1.30e-03 | BRCA |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| MATN2 | 1.99e+03 | -1.18e+00 | 2.20e-01 | -5.34e+00 | 9.21e-08 | 3.88e-07 | KIRP |
| MATN2 | 1.15e+03 | -1.81e+00 | 4.37e-01 | -4.14e+00 | 3.52e-05 | 1.74e-04 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| MATN2 | 2.83e+03 | -1.25e+00 | 4.39e-01 | -2.84e+00 | 4.54e-03 | 1.85e-02 | STAD |
| MATN2 | 2.94e+03 | -2.53e+00 | 1.40e-01 | -1.81e+01 | 1.60e-73 | 3.16e-72 | BRCA |
| MATN2 | 1.77e+03 | -1.96e+00 | 5.23e-01 | -3.74e+00 | 1.82e-04 | 8.01e-04 | READ |
Top |
Sex-biased somatic mutation for MATN2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for MATN2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg10039928 | chr8:97868632 | CGI:chr8:97868809-97869615 | promoter | 4.31e-01 | 5.33e-01 | -4.36e+00 | 1.29e-05 | 3.40e-05 | -1.02e-01 |
| KIRC | cg09093931 | chr8:97868698 | CGI:chr8:97868809-97869615 | promoter | 2.22e-01 | 3.43e-01 | -5.19e+00 | 2.09e-07 | 9.38e-07 | -1.21e-01 |
| LUSC | cg10039928 | chr8:97868632 | CGI:chr8:97868809-97869615 | promoter | 3.68e-01 | 4.79e-01 | -3.27e+00 | 1.06e-03 | 2.70e-03 | -1.11e-01 |
| LUSC | cg09093931 | chr8:97868698 | CGI:chr8:97868809-97869615 | promoter | 2.25e-01 | 3.47e-01 | -3.61e+00 | 3.03e-04 | 1.23e-03 | -1.22e-01 |
| BLCA | cg16129200 | chr8:97867665 | CGI:chr8:97868809-97869615 | promoter | 3.83e-01 | 6.20e-01 | -3.43e+00 | 6.14e-04 | 1.56e-03 | -2.37e-01 |
| BLCA | cg09093931 | chr8:97868698 | CGI:chr8:97868809-97869615 | promoter | 1.99e-01 | 3.22e-01 | -3.82e+00 | 1.33e-04 | 4.92e-04 | -1.22e-01 |
| LIHC | cg16129200 | chr8:97867665 | CGI:chr8:97868809-97869615 | promoter | 4.22e-01 | 5.50e-01 | -3.91e+00 | 9.39e-05 | 1.95e-04 | -1.28e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg09093931 | chr8:97868698 | CGI:chr8:97868809-97869615 | promoter | 2.54e-01 | 3.56e-01 | -3.13e+00 | 1.74e-03 | 4.64e-03 | -1.02e-01 |
Top |
Exon skipping events with PSI in TCGA for MATN2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for MATN2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for MATN2 |
| TFs related to MATN2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| MESO | ZNF418 | MATN2 | 2.45e+00 | 8.66e-04 | 4.40e+00 | 9.91e-01 | Female-biased |
| MESO | ZNF79 | MATN2 | 2.83e+00 | 7.15e-03 | 4.19e+00 | 9.81e-01 | Female-biased |
| SKCM | FOXD3 | MATN2 | 2.75e+00 | 1.47e-03 | 4.32e+00 | 9.81e-01 | Female-biased |
| SKCM | FOXO1 | MATN2 | 3.51e+00 | 6.85e-03 | 4.60e+00 | 9.81e-01 | Female-biased |
| SKCM | FOXP3 | MATN2 | 3.45e+00 | 3.98e-03 | 4.72e+00 | 9.86e-01 | Female-biased |
| SKCM | FOXR2 | MATN2 | 2.37e+00 | 4.03e-04 | 4.30e+00 | 9.82e-01 | Female-biased |
| SKCM | LHX2 | MATN2 | 3.72e+00 | 7.36e-03 | 4.80e+00 | 9.84e-01 | Female-biased |
| SKCM | LHX6 | MATN2 | 4.06e+00 | 1.17e-02 | 4.99e+00 | 9.81e-01 | Female-biased |
| SKCM | LHX9 | MATN2 | 3.56e+00 | 6.11e-03 | 4.69e+00 | 9.83e-01 | Female-biased |
| SKCM | NFIL3 | MATN2 | 4.10e+00 | 1.10e-02 | 5.05e+00 | 9.83e-01 | Female-biased |
| SKCM | NKX3-2 | MATN2 | 3.27e+00 | 3.88e-03 | 4.55e+00 | 9.84e-01 | Female-biased |
| SKCM | ONECUT3 | MATN2 | 3.17e+00 | 3.94e-03 | 4.44e+00 | 9.82e-01 | Female-biased |
| SKCM | PDX1 | MATN2 | 3.52e+00 | 5.59e-03 | 4.69e+00 | 9.84e-01 | Female-biased |
| SKCM | POU4F1 | MATN2 | 2.99e+00 | 2.44e-03 | 4.41e+00 | 9.82e-01 | Female-biased |
| SKCM | POU4F3 | MATN2 | 3.18e+00 | 3.29e-03 | 4.51e+00 | 9.83e-01 | Female-biased |
| SKCM | SOX15 | MATN2 | 3.35e+00 | 4.87e-03 | 4.55e+00 | 9.83e-01 | Female-biased |
| SKCM | SOX2 | MATN2 | 3.45e+00 | 4.64e-03 | 4.67e+00 | 9.85e-01 | Female-biased |
| SKCM | SOX5 | MATN2 | 3.84e+00 | 5.21e-03 | 5.03e+00 | 9.88e-01 | Female-biased |
| SKCM | SRY | MATN2 | 3.39e+00 | 3.86e-03 | 4.67e+00 | 9.85e-01 | Female-biased |
| SKCM | ZNF580 | MATN2 | 3.14e+00 | 1.79e-03 | 4.65e+00 | 9.87e-01 | Female-biased |
| SKCM | ZNF79 | MATN2 | 2.21e+00 | 2.61e-04 | 4.26e+00 | 9.81e-01 | Female-biased |
| MATN2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for MATN2 |
| RBPs related to ES in MATN2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHOL | SRSF7 | exon_skip_485136 | 1.06e+01 | 9.89e-01 | 1.02e+01 | 1.00e-02 | Male-biased |
| ESCA | ANKHD1 | exon_skip_485121 | 1.60e+01 | 1.52e-03 | 1.67e+01 | 9.98e-01 | Female-biased |
| PCPG | KHDRBS2 | exon_skip_485126 | 7.84e+00 | 9.82e-01 | 7.50e+00 | 8.41e-03 | Male-biased |
| KICH | RBM5 | exon_skip_485128 | 9.29e+00 | 9.87e-01 | 8.97e+00 | 1.01e-02 | Male-biased |
| MATN2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000132561 | DHRS4-AS1,hsa-mir-202,MATN2 | Male-specific ceRNA | TCGA-KIRP |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs3134257 | chr8:103423309:C:A | - | 0.129977983371652 | 0.0407009193928473 | STAD | Female-baised eQTL |
| rs10097386 | chr8:92633008:C:T | - | 0.0623215097729051 | 0.0299658161379524 | LGG | Female-baised eQTL |
| rs1449239 | chr8:92634427:T:C | - | 0.0624661775179948 | 0.0307857744306804 | LGG | Female-baised eQTL |
| rs12675482 | chr8:92631642:C:T | - | 0.0624219294849704 | 0.0311353524120036 | LGG | Female-baised eQTL |
| rs10956851 | chr8:92627004:C:T | - | 0.0627277527395151 | 0.0349617289820529 | LGG | Female-baised eQTL |
| rs12335130 | chr8:95148461:C:G | - | 0.0724774426501593 | 0.0161575796247492 | KIRC | Female-baised eQTL |
| rs60036223 | chr8:95136284:A:G | - | 0.0714995243133624 | 0.019911401102089 | KIRC | Female-baised eQTL |
| rs2053893 | chr8:89147842:C:A | - | -0.10598671752276 | 0.0230403886820911 | KIRC | Female-baised eQTL |
| rs10087996 | chr8:96963357:A:T | - | 0.124631231039437 | 0.0241786311540023 | KIRC | Female-baised eQTL |
| rs62518677 | chr8:92570730:T:G | - | 0.135101141139789 | 0.0283312653815514 | KIRC | Female-baised eQTL |
| rs11987777 | chr8:97019990:T:C | - | 0.120987817454166 | 0.0286383383624446 | KIRC | Female-baised eQTL |
| rs905556 | chr8:106343451:A:G | - | 0.072349442449547 | 0.0308575614520357 | KIRC | Female-baised eQTL |
| rs28820108 | chr8:97021654:A:C | - | 0.123709430265083 | 0.0343761111530222 | KIRC | Female-baised eQTL |
| rs28749318 | chr8:97020141:T:A | - | 0.118684339631756 | 0.0460566048866606 | KIRC | Female-baised eQTL |
| rs3890744 | chr8:97030697:C:T | - | 0.202543143503334 | 0.0195083522896324 | BLCA | Female-baised eQTL |
| rs6994621 | chr8:97047175:T:C | - | 0.187424792418279 | 0.037912540422293 | BLCA | Female-baised eQTL |
| rs73695756 | chr8:97050608:T:C | - | 0.187163735540326 | 0.0383246171614107 | BLCA | Female-baised eQTL |
| rs10089867 | chr8:97063656:A:G | - | 0.187163735540326 | 0.0383246171614107 | BLCA | Female-baised eQTL |
| rs11990753 | chr8:97069471:A:C | - | 0.187163735540326 | 0.0383246171614107 | BLCA | Female-baised eQTL |
| rs7010155 | chr8:106544992:A:G | - | 0.0807703009176783 | 0.00783555923408082 | LUAD | Female-baised eQTL |
| rs76611715 | chr8:105908646:G:A | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs60859367 | chr8:105915240:T:G | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs59483767 | chr8:105915690:C:T | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs78355739 | chr8:105916079:A:C | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs76058931 | chr8:105917218:C:A | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs1603360 | chr8:105918434:C:A | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs75275129 | chr8:105919079:A:G | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs75559883 | chr8:105923241:C:A | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs76297930 | chr8:105924687:T:C | - | 0.0672995303703341 | 0.0110886205559547 | LUAD | Female-baised eQTL |
| rs76173617 | chr8:106575145:T:C | - | 0.0739250296369437 | 0.0452207038885084 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73268397 | chr8:95342102:C:T | - | 0.299658445930082 | 0.0227336695439999 | READ | Male-baised eQTL |
| rs11985598 | chr8:95894765:C:T | - | 0.0370964819460229 | 0.0130718008894705 | KIRC | Male-baised eQTL |
| rs16894144 | chr8:95945990:T:G | - | 0.0379260461105958 | 0.0136988042673541 | KIRC | Male-baised eQTL |
| rs10091342 | chr8:95895457:C:T | - | 0.0368763471936087 | 0.0141179624635796 | KIRC | Male-baised eQTL |
| rs10094696 | chr8:95895863:C:T | - | 0.0368763471936087 | 0.0141179624635796 | KIRC | Male-baised eQTL |
| rs10094475 | chr8:95895771:A:T | - | 0.036799533198482 | 0.0146292694358257 | KIRC | Male-baised eQTL |
| rs28499400 | chr8:95922664:T:C | - | 0.037685983728953 | 0.0150542914818175 | KIRC | Male-baised eQTL |
| rs2013433 | chr8:95924073:C:T | - | 0.037685983728953 | 0.0150542914818175 | KIRC | Male-baised eQTL |
| rs75309424 | chr8:95596411:T:C | - | 0.0551024099249523 | 0.0156693008712397 | KIRC | Male-baised eQTL |
| rs7357516 | chr8:95941795:G:A | - | 0.0366279803814787 | 0.0194721188117014 | KIRC | Male-baised eQTL |
| rs10113520 | chr8:95936276:C:T | - | 0.0358551544194202 | 0.0200283767955313 | KIRC | Male-baised eQTL |
| rs57360858 | chr8:95891284:G:A | - | 0.0378942584861352 | 0.021253948938832 | KIRC | Male-baised eQTL |
| rs2305832 | chr8:102254577:C:A | - | 0.0539329186225175 | 0.0243230398378748 | KIRC | Male-baised eQTL |
| rs7845444 | chr8:95914366:C:G | - | 0.0366459620520229 | 0.02528166801227 | KIRC | Male-baised eQTL |
| rs7462810 | chr8:94707805:C:G | - | 0.0316367900202893 | 0.027694196922788 | KIRC | Male-baised eQTL |
| rs67763699 | chr8:103345161:C:T | - | 0.0416584975914513 | 0.0282827264736282 | KIRC | Male-baised eQTL |
| rs1975282 | chr8:95897429:C:A | - | 0.0361070990303293 | 0.0314401006098011 | KIRC | Male-baised eQTL |
| rs34342692 | chr8:95897996:G:A | - | 0.0361070990303293 | 0.0314401006098011 | KIRC | Male-baised eQTL |
| rs16904279 | chr8:90289949:A:G | - | 0.0271108620789533 | 0.0391619121768916 | KIRC | Male-baised eQTL |
| rs10504958 | chr8:95947591:T:C | - | -0.0268590259208677 | 0.0394923202779483 | KIRC | Male-baised eQTL |
| rs9643257 | chr8:90246171:T:C | - | 0.0284055137340283 | 0.0415441160287542 | KIRC | Male-baised eQTL |
| rs2879344 | chr8:90264815:G:A | - | 0.0290687962960522 | 0.0418803038977729 | KIRC | Male-baised eQTL |
| rs56295922 | chr8:90245823:A:T | - | 0.0281774311049258 | 0.0448607155817348 | KIRC | Male-baised eQTL |
| rs9643256 | chr8:90244696:C:T | - | 0.0278992251134071 | 0.0486565150226553 | KIRC | Male-baised eQTL |
| rs10086980 | chr8:90245444:A:G | - | 0.0278992251134071 | 0.0486565150226553 | KIRC | Male-baised eQTL |
| rs2514329 | chr8:98241781:G:C | - | -0.0627427034132462 | 0.000171356254688886 | BLCA | Male-baised eQTL |
| rs2443566 | chr8:98241411:C:T | - | -0.0599380313326842 | 0.000863955425864525 | BLCA | Male-baised eQTL |
| rs2514328 | chr8:98239887:G:A | - | -0.0599612752259084 | 0.000864218777896183 | BLCA | Male-baised eQTL |
| rs2443567 | chr8:98241649:G:A | - | -0.0592032947817706 | 0.00103510756273925 | BLCA | Male-baised eQTL |
| rs2443568 | chr8:98241817:C:T | - | -0.0592032947817706 | 0.00103510756273925 | BLCA | Male-baised eQTL |
| rs4454248 | chr8:98242315:G:T | - | -0.0593644022997732 | 0.00111397662031443 | BLCA | Male-baised eQTL |
| rs2443569 | chr8:98242093:G:C | - | -0.0586562307167263 | 0.00131406255724033 | BLCA | Male-baised eQTL |
| rs3102495 | chr8:95657319:A:C | - | -0.0659902149477763 | 0.00237903455239948 | BLCA | Male-baised eQTL |
| rs1449789 | chr8:99751449:T:G | - | -0.0888312577146043 | 0.0133491135205954 | LUAD | Male-baised eQTL |
| rs75309424 | chr8:95596411:T:C | - | 0.0692996730109011 | 0.0449916035809241 | LUAD | Male-baised eQTL |
| rs2607066 | chr8:94229250:A:G | - | 0.152574395091457 | 0.0447354953198334 | COAD | Male-baised eQTL |
| rs2607067 | chr8:94229627:C:T | - | 0.152574395091457 | 0.0447354953198334 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000132561 |
| CpG Site: cg16016960 | |
| Position to Gene: gene,enhancer | |
| Male Effect: - | |
| Female Effect: -0.328242766481957 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg16016960 | chr8:97870998 | gene,enhancer | -0.328242766481957 | 2.70571738013533e-07 | -0.3816509215955518 | 2.885779411608396e-10 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of MATN2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
